SCHEMBL6016757

SCHEMBL6016757

C=CCn1cnc2cnc(Cl)nc21

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 1/20 0.46
FGFR4 P22455 1/20 0.46
ADORA2B P29275 2/20 0.36
HIF1A Q16665 1/20 0.36
ALDH1A1 P00352 5/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HPGD P15428 3/20 0.35
KDM4E B2RXH2 2/20 0.35
HSD17B10 Q99714 2/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
PDE4B Q07343 2/20 0.33
PDE4D Q08499 2/20 0.33
HDAC6 Q9UBN7 1/20 0.33
PDE4A P27815 1/20 0.33
ADORA2A P29274 1/20 0.33
PDE4C Q08493 1/20 0.33
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30586403 1.00 FGFR1 (0.46) FGFR1FGFR4ADORA2BHIF1AALDH1A1
SCHEMBL30586369 0.84 HIF1A (0.35) FGFR1FGFR4ADORA2BHIF1AALDH1A1
SCHEMBL8407003 0.81 ADORA2B (0.36) FGFR1FGFR4ADORA2BHIF1AALDH1A1
SCHEMBL4551666 0.81 HDAC6 (0.46) FGFR1FGFR4ADORA2BHIF1AALDH1A1
SCHEMBL5839419 0.78 FGFR1 (0.40) FGFR1FGFR4ALDH1A1HPGDKDM4E
SCHEMBL28184787 0.76 FGFR1 (0.45) FGFR1FGFR4ADORA2BALDH1A1HPGD
SCHEMBL28232173 0.75 FGFR1 (0.39) FGFR1FGFR4ALDH1A1HPGDKDM4E
SCHEMBL29141665 0.75 ADORA2A (0.41) FGFR1FGFR4ADORA2BHIF1AALDH1A1
SCHEMBL27773226 0.74 POLB (0.44) FGFR1FGFR4HIF1AALDH1A1HPGD
SCHEMBL29601304 0.74 FGFR1 (0.41) FGFR1FGFR4ADORA2BALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030187261-A1 Purine derivatives, process for their preparation and use thereof USTAV EXPERIMANTALNI BOTANIKY AKADEMIE VED CESKE REPUBLIKY (CZ) 2003-10-02 US claimed
EP-1244668-A1 PURINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND USE THEREOF UNIVERSITAIRE INSTELLING ANTWERPEN (BE) 2002-10-02 EP claimed
WO-2001049688-A1 PURINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND USE THEREOF UNIVERSITAIRE INSTELLING ANTWERPEN (BE) 2001-07-12 WO claimed
EP-1244668-B1 PURINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND USE THEREOF UNIVERSITAIRE INSTELLING ANTWE (BE) 2006-04-05 EP disclosed
US-20030187261-A1 Purine derivatives, process for their preparation and use thereof USTAV EXPERIMANTALNI BOTANIKY AKADEMIE VED CESKE REPUBLIKY (CZ) 2003-10-02 US disclosed
EP-1244668-A1 PURINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND USE THEREOF UNIVERSITAIRE INSTELLING ANTWERPEN (BE) 2002-10-02 EP disclosed
WO-2001049688-A1 PURINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND USE THEREOF UNIVERSITAIRE INSTELLING ANTWERPEN (BE) 2001-07-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187261-A1 Purine derivatives, process for their preparation and use thereof DCK, DTYMK, CCNK FGFR1 3829/4885FGFR4 3561/4885ADORA2B 1224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.